Growing Cases Of Dry Eye Disease Drive Demand For Treatment And Fuel Market Growth: Strengthening the Growth Trajectory of the Dry Eye Medication Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Dry Eye Medication Industry Market Size Be by 2025?
The market size for dry eye medication has seen considerable expansion in recent years. The market, which stood at $11.01 billion in 2024, is projected to reach $12.37 billion in 2025, presenting an impressive compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth throughout the historic period include an aging population, a growing number of individuals using contact lenses, increased disposable income, greater availability of treatment options, a surge in allergy cases, a rise in consumption of unhealthy or inappropriate food, and the widespread nature of diabetes mellitus.

What's the Long-Term Growth Forecast for the Dry Eye Medication Market Size Through 2029?
The market size for dry eye treatments is anticipated to experience substantial growth in the upcoming years, skyrocketing to $18.71 billion in 2029, with a compound annual growth rate (CAGR) of 10.9%. This forecasted growth can be linked to multiple factors such as an increase in laser surgeries, extended screen time, hectic lifestyle schedules, a growing diabetes concern, higher incidence of dry eye disease, a robust development pipeline for dry eye disease, and negative consequences from other medications. The forecast period will also see major trends like the introduction of preservative-free eye drops, increased investment in the research and creation of advanced medications, the invention of cutting-edge drugs to maintain industry relevance, the production of non-steroidal anti-inflammatory ocular drugs to treat dry eye syndrome, an emphasis on integrating modern methods, and the creation of combination treatments for dry eye diseases.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

What Are the Key Growth Drivers Fueling the Dry Eye Medication Market Expansion?
An escalating number of dry eye disease instances is leading to a surge in the requirement for its treatment. Certain factors such as aging, a deficiency in vitamin A, lens usage, eye surgeries, and exposure to dry wind, smoke, or prolonged screen time significantly heighten the risk of dry eye occurrence. For instance, the American Academy of Ophthalmology reported in a survey that nearly 3.2 million women and 1.68 million men, above 50 years of age, are afflicted with dry eye syndrome in the USA. Analogously, a study performed by the Indian Journal of Ophthalmology revealed a 32% incidence of dry eye disease in the Northern region of India. The soaring prevalence of the disease is expected to boost the need for its treatment, thus fostering the growth of the dry eye medication market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3807&type=smp

What Are the Key Trends Driving Dry Eye Medication Market Growth?
Leading businesses in the dry eye medication industry are advancing their offerings through the creation of groundbreaking products like Cyclosporine ophthalmic solutions. These are designed to increase tear production, decrease eye inflammation, and offer long-lasting relief. The primary use of Cyclosporine-prescribed eye drops, which contain the immunosuppressive agent cyclosporin, is to combat dry eye syndrome by enhancing tear production and mitigating eye inflammation. For example, in June 2023, German biopharmaceutical company Novaliq GmbH reported that the U.S. FDA had permitted the usage of VEVYE (cyclosporine ophthalmic solution) 0.1% for diagnosing and treating dry eye disease. VEVYE (with its development name CyclASol) received the honor of being the first and exclusive cyclosporine solution approved to specifically address dry eye disease indicators and symptoms, showing impressive results within just a month of usage. VEVYE, crafted with a new water-free ingredient, caters to patient needs by acting quickly and showing a high tolerance for dry eye treatment. Its formula, which is devoid of water, anti-microbial preservatives, oils, and surfactants, removes negative side-effects linked to pH and osmolarity.

How Is the Dry Eye Medication Market Segmented?
The dry eye medication market covered in this report is segmented -

1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative
2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System
3) By Prescription Type: OTC Drugs, Prescription Drugs
4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Aqueous: Artificial Tears (lubricating eye drops), Prescription Eye Drops, Ophthalmic Solutions
2) By Evaporative: Punctal Plugs (to reduce tear drainage), Lipid-Based Eye Drops, Eye Ointments (with lipid components)
3) By Aqueous and Evaporative: Combination Eye Drops (formulated to address both aqueous And evaporative dry eye), Multi-Action Eye Care Products

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3807&type=smp

Which Companies Are Leading the Charge in Dry Eye Medication Market Innovation?
Major companies operating in the dry eye medication market include Allergan plc, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., OASIS Medical, Inc., VISUfarma B.V., Sun Pharmaceutical Industries Limited, Bayer AG, Pfizer, Johnson & Johnson, Daiichi Sankyo, Zhaoke Ophthalmology Pharmaceutical, Vision gain, Implandata ophthalmic products GmbH, The Geuder Group, Novamedika, Aflofarm Farmacja Polska, VUAB Pharma Inc., Herzig Eye Institute, Thomas Eye Group, Alimera Sciences, Eyegate, Neurotech, Opthotech, Eyepoint pharmaceuticals, ReGenTree, LLC, Regenerx Biopharmaceuticals Inc, shire, Gama Vision, Biolab Pharma, Mitotech, Novaliq GmbH, Horus Pharma, Prestige Consumer Healthcare Inc., Azura Ophthamics Ltd, Similasan, Hoya Corporation, Adcock Ingram.

Which Regions Are Leading the Global Dry Eye Medication Market in Revenue?
North America was the largest region in the market in 2024. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3807

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.